23-substituted bile acids as TGR5 modulators and methods of use thereof

Details for Australian Patent Application No. 2008209566 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto

Agent Cullens

Pub. Number AU-B-2008209566

PCT Pub. Number WO2008/091540

Priority 07012079.5 20.06.07 EP; 07001143.2 19.01.07 EP

Filing date 18 January 2008

Wipo publication date 31 July 2008

Acceptance publication date 20 September 2012

International Classifications

C07J 9/00 Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/575 - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

C07J 31/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

C07J 41/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/091540 Priority application(s): WO2008/091540

10 September 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Aug 2009

20 September 2012 Application Accepted

  Published as AU-B-2008209566

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209568-Polyaxial bone screw with cam capture

2008209561-Apparatus for high throughput chemical reactions